Miscellaneous Quiz / Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/68 Timer 20:00
HintAnswer
Baclofen class
Venlafaxine class
Modafinil class
Plasmapheresis class
First line RRMS agent injected SC daily
Second line agent for RRMS that produces reduction in progression of disabilty
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: IM weekly
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Mitoxantrone class
Second line agent: RRMS. Reduced relapses & progression of disability
Methylphenidate class
Use: Fatigue, cognitive impairment (long acting agent)
Mycophenolate class
Bupropion class
Cyclophosphamide class
Use: Fatigue
Carbamazepine class
Dose: 1250 mg/day PO for 3-5 days
MOA: Antimetabolite and antifolate
Axathioprine class
HintAnswer
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Gabapentin class
Excreted by kidney: contraindicated in moderate to severe renal failure
Off line agent used in the treatment of acute attacks
Methylprednisone class
MOA: Purine analog
Natalizumab class
Dose: Oral. In extreme cases intrathecal
Dose: Oral daily (first PO MS drug)
Rituximab class
Use: Depression. Also helps with pain
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
IFN beta 1-a (Rebif) class
Dose: 1 gram/day IV for 3-5 days
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
First line drugs for disease modification
Duloxetine class
Dose: SC injection every other day
Use: For pts who do not respond to corticosteroids during acute attacks
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dalfampridine class
Tizanidine class
Glatiramer acetate class
HintAnswer
Alemtizumab class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Daclizumab class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Use: pain and paroxysmal disorders
IFN beta 1-a (Avonex) class
MOA: alkylating agent
Fingolimod class
Second line agent given IV monthy
Dose: IV infusion every 3 months
Tricyclic class
Use: treatment of spasticity
Use: Depression. Also helps with fatigue
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
IFN beta 1-b (Betaseron) class
MOA: Anti-organ rejection drug
Second line agent MOA: monoclonal Ab
Dose: SC injection 2-3 times weekly
MOA: Immunomodulator/antineoplastic
MOA: Immune modulator, exact mechanism not known.
Methotrexate class
Prednisone class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.